Serum iron and transferrin in acute neuroleptic induced akathisia

O'Loughlin, V; Dickie, A C; Ebmeier, K P
April 1991
Journal of Neurology, Neurosurgery & Psychiatry;Apr1991, Vol. 54 Issue 4, p363
Academic Journal
journal article
No abstract available.


Related Articles

  • Serum Iron Abnormalities in Neuroleptic-Induced Akathisia in Schizophrenic Patients. Soni, Som D.; Tench, David; Routledge, R. C. // British Journal of Psychiatry;Nov93, Vol. 163, p669 

    Twenty-two schizophrenic patients (DSM-III-R criteria) with clinically significant akathisia were matched with 22 schizophrenic patients without akathisia on the following variables: age, sex, diagnosis, duration of illness, and current treatment. Both groups were assessed using a variety of...

  • Correlations Between Akathisia and Residual Psychopathology: A By-product of Neuroleptic-Induced Dysphoria. Newcomer, John W.; Miller, L. Stephen; Faustman, William O.; Wetzel, Martin W.; Vogler, George P.; Csernansky, John G. // British Journal of Psychiatry;Jun94, Vol. 164, p834 

    Patients developing neuroleptic-induced akathisia have been reported to show higher levels of psychopathology. We sought to replicate this finding and determine its symptom specificity. We confirmed a significant relation- ship between ratings of akathisia and total score on the Brief...

  • Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem. Poyurovsky, Michael; Weizman, Abraham // British Journal of Psychiatry;Jul2001, Vol. 179, p4 

    The article discusses the serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia (NIA). According to the author, the new approach is characterized by a subjective sense of inner restlessness and objective fidgety movements. NIA is a major extrapyramidal side-effect of...

  • A Controlled Assessment of Propranolol in the Treatment of Neuroleptic-Induced Akathisia. Adler, Lenard; Angrist, Burt; Peselow, Eric; Corwin, June; Maslansky, Robert; Rotrosen, John // British Journal of Psychiatry;Jul86, Vol. 149, p42 

    Twelve patients with neuroleptic-induced akathisia were treated in a randomised, double-blind, cross-over design with propranolol and matching placebo. Propranolol caused significant decrements in both subjective and objective ratings of akathisia, but not in anxiety scores. This confirms prior...

  • Relationship Between Iron Status and Chronic Akathisia in an In-patient Population with Chronic Schizophrenia. Barnes, Thomas R. E.; Halstead, Simon M.; Little, Patrick W. A. // British Journal of Psychiatry;Dec92, Vol. 161, p791 

    Iron status and akathisia were assessed in 105 long-stay in-patients who fulfilled DSM-lll-R criteria for schizophrenia, all but three of whom were receiving antipsychotic medication. Chronic akathisia was diagnosed in 23% and pseudoakathisia in 20%. No significant correlation was found between...

  • Managing antipsychotic-induced acute and chronic akathisia. Miller, C.H.; Fleischhacker, W.W. // Drug Safety;Jan2000, Vol. 22 Issue 1, p73 

    Akathisia is a frequent and common adverse effect of treatment with antipsychotic (neuroleptic) drugs. This syndrome consists of subjective (feeling of inner restlessness and the urge to move) as well as objective components (rocking while standing or sitting, lifting feet as if marching on the...

  • Infectious effect on iron. M.O.R. // Cortlandt Forum;02/25/98, Vol. 11 Issue 2, p133 

    Comments on the infectious effect of febrile infection on the level of iron and serum transferrin of a patient. Iron as a defense mechanism against infection.

  • Akathisia--or not sitting. Szabadi, E. // British Medical Journal (Clinical Research Edition);4/19/1986, Vol. 292 Issue 6527, p1034 

    Describes the clinical manifestation of akathisia. Description of the disease; Role of neuroleptic drugs in the formation of akathisia; Syndromes accompanying the ailment.

  • A Pitfall in the Interpretation of Serum Iron Values. Hilal, Hashim; McCurdy, Paul R. // Annals of Internal Medicine;May67, Vol. 66 Issue 5, p983 

    Demonstrates that the serum iron and the percent saturation of transferrin decrease after acceleration of erythropoiesis. Information on the percent saturation of serum transferrin; Factors that suggest a diagnosis of iron deficiency; Changes that occur when megaloblastic anemia is treated with...

  • No Correlation between Neuroleptic-induced Increase of β-Endorphin Serum Level and Therapeutic Efficacy in Schizophrenia. Naber, D.; Nedopil, N.; Eben, E. // British Journal of Psychiatry;Jun84, Vol. 144, p651 

    In 23 acute, unmedicated, schizophrenic patients, psychotic behaviour and β-endorphin serum level were measured before and during four weeks of neuroleptic therapy. Prior to drug treatment, β-endorphin level of all patients was within the normal range. Neuroleptic therapy induced marked...


Read the Article


Sign out of this library

Other Topics